Expanding and Optimizing the RBM Model
Biopharma is adopting Risk-based Monitoring (RBM) as
the standard execution model for clinical studies. As the RBM market leader,
Quintiles is leading this evolution. Now, you can gain from our industry-leading
RBM approach with a standalone Centralized Monitoring capability, which
integrates our operational expertise, data integration, technology, predictive
and advanced analytics, and site and patient management.
Flexibility and Value
Optimize your existing clinical operations by using
Quintiles’ Centralized Monitoring. Our offering’s proven processes are enabled
by an advanced technology platform that is implemented and supported by established
change management methodologies. Integrate Quintiles' adaptable Centralized
Monitoring capabilities, which allow you to select the services that best meet
your unique requirements with your monitoring approach, or into your existing
Functional Service Provider (FSP) model, to drive your clinical development
Use Quintiles Centralized Monitoring services with your existing services to accelerate your RBM benefits and more easily connect insights for better outcomes.